Researcher
Sandra Van Lint
- Research Expertise:
- RNA & DNA
- in vivo experiments
- immunological techniques
- Keywords:Medicine
- Disciplines:Humanities and the arts, Engineering and technology, Natural sciences
- Users of research expertise:
- RNA & DNA
- in vivo experiments
- immunological techniques
Affiliations
- Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 28 Feb 2015 - Laboratory of Molecullar and Cellular Therapy (Research group)
Member
From1 Aug 2007 → 28 Feb 2015 - Physiology (Department)
Member
From16 Jul 2007 → 31 Dec 2013
Publications
1 - 10 of 12
- mRNA in cancer immunotherapy(2021)
Authors: Lien Van Hoecke, Rein Verbeke, Heleen Dewitte, Ine Lentacker, Karim Vermaelen, Karine Breckpot, Sandra Van Lint
- Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells(2016)
Authors: Sandra Van Lint, Dries Renmans, Katrijn Broos, Lode Goethals, Sarah Maenhout, Daphné Benteyn, Cleo Goyvaerts, Stephanie Du Four, Kevin Van der Jeught, Lukasz Bialkowski, et al.
Pages: 146-156 - Intratumoral delivery of mRNA(2015)
Authors: Kevin Van der Jeught, Sandra Van Lint, Kris Thielemans, Karine Breckpot
Pages: e1005504 - The ReNAissanCe of mRNA-based cancer therapy(2015)
Authors: Sandra Van Lint, Dries Renmans, Katrijn Broos, Heleen Dewitte, Ines Lentacker, Carlo Heirman, Karine Breckpot, Kris Thielemans
Pages: 235-251 - mRNA sonoporation as a novel tool in dendritic cell-based cancer immunotherapy(2012)
Authors: Heleen Dewitte, Sandra Van Lint, Stefaan De Smedt, Karine Breckpot, I. Lentacker
Pages: A92-A93 - Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy(2012)
Authors: Sandra Van Lint, Cleo Goyvaerts, Sarah Maenhout, Lode Goethals, Aurélie Disy, Daphné Benteyn, Joeri Pen, Carlo Heirman, Karine Breckpot, Kris Thielemans
Pages: 1661-1671 - Proinflammatory Characteristics of SMAC/DIABLO-Induced Cell Death in Antitumor Therapy(2012)
Authors: Perpetua Emeagi, Sandra Van Lint, Cleo Goyvaerts, Sarah Maenhout, A. Cauwels, I.a. Mcneish, Tomas Bos, Carlo Heirman, Kris Thielemans, Joeri L Aerts, et al.
Pages: 1342-1352 - Development of the nanobody display technology to target lentiviral vectors to antigen-presenting cells(2012)
Authors: Cleo Goyvaerts, Kurt De Groeve, Jozef Dingemans, Sandra Van Lint, Lander Robays, Carlo Heirman, J. Reiser, X-Y Zhang, Kris Thielemans, Patrick De Baetselier, et al.
Pages: 1133-1140 - HIV-1 lentiviral vector immunogenicity is mediated by TLR3 and TLR7(2010)
Authors: Karine Breckpot, D. Escors, F. Arce, L. Lopes, K. Karwacz, Sandra Van Lint, Marleen Keyaerts, M. Collins
Pages: 5627-5636 - HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7(2010)
Authors: Karine Breckpot, D. Escors, F. Arce, L. Lopes, K. Karwacz, Sandra Van Lint, Marleen Keyaerts, M. Collins
Pages: 5627-5636